Iran Mass-Produces Domestic COVID-19 Vaccine
TEHRAN (Dispatches) -- Iran on Tuesday started mass production of its domestic vaccine for COVID-19, named COV-Iran Barekat.
Iran plans to produce 1 million doses of COV-Iran Barekat by May 21, and around 10 million doses of the vaccine will be supplied by June, said Hojjat Niki Maleki, director of the information department of the Barekat Foundation, which is mass-producing the vaccine.
The COV-Iran vaccine has gone through three stages of clinical trials, the last of which involved 20,000 people in the cities of Tehran, Bushehr, Shiraz, Karaj, Mashhad and Isfahan, the report said.
Iran has already granted emergency use authorization to Russian-made Sputnik V vaccine, Covaxin made by India’s Bharat Biotech, Oxford/AstraZeneca developed by Russia’s R-Pharm Group, and the AstraZeneca-SKBio made in South Korea.
On Sunday, Iranian President Hassan Rouhani unveiled plans to vaccinate 13 million high-risk people eligible for the coronavirus vaccine by July 22.
Over 18,000 New Cases Detected
The Health Ministry’s spokeswoman Sima Sadat Lari said the number of new coronavirus cases detected in Iran exceeded 18,000.
Speaking at a press conference, Lari said the total number of people tested positive for COVID-19 in Iran has surpassed 2.69 million after the detection of 18,133 new cases.
Of the new cases detected over, 2,575 patients have been admitted to the hospital, she added.
Among those undergoing treatment in medical centers at present, 5,522 coronavirus patients have critical health conditions because of more severe infection, Lari noted.
She further put the death toll from COVID-19 in Iran at 75,568, saying
the disease has taken the lives of 307 patients over the past 24 hours.
At least 2,144,197 patients have recovered from the coronavirus infection so far or have been discharged from hospitals across Iran, the spokeswoman said.
Iran has so far registered more than 2.6 million coronavirus cases and over 75,000 deaths.
Iran plans to produce 1 million doses of COV-Iran Barekat by May 21, and around 10 million doses of the vaccine will be supplied by June, said Hojjat Niki Maleki, director of the information department of the Barekat Foundation, which is mass-producing the vaccine.
The COV-Iran vaccine has gone through three stages of clinical trials, the last of which involved 20,000 people in the cities of Tehran, Bushehr, Shiraz, Karaj, Mashhad and Isfahan, the report said.
Iran has already granted emergency use authorization to Russian-made Sputnik V vaccine, Covaxin made by India’s Bharat Biotech, Oxford/AstraZeneca developed by Russia’s R-Pharm Group, and the AstraZeneca-SKBio made in South Korea.
On Sunday, Iranian President Hassan Rouhani unveiled plans to vaccinate 13 million high-risk people eligible for the coronavirus vaccine by July 22.
Over 18,000 New Cases Detected
The Health Ministry’s spokeswoman Sima Sadat Lari said the number of new coronavirus cases detected in Iran exceeded 18,000.
Speaking at a press conference, Lari said the total number of people tested positive for COVID-19 in Iran has surpassed 2.69 million after the detection of 18,133 new cases.
Of the new cases detected over, 2,575 patients have been admitted to the hospital, she added.
Among those undergoing treatment in medical centers at present, 5,522 coronavirus patients have critical health conditions because of more severe infection, Lari noted.
She further put the death toll from COVID-19 in Iran at 75,568, saying
the disease has taken the lives of 307 patients over the past 24 hours.
At least 2,144,197 patients have recovered from the coronavirus infection so far or have been discharged from hospitals across Iran, the spokeswoman said.
Iran has so far registered more than 2.6 million coronavirus cases and over 75,000 deaths.